Sign up for our free daily newsletter
YOUR PRIVACY - PLEASE READ CAREFULLY DATA PROTECTION STATEMENT
Below we explain how we will communicate with you. We set out how we use your data in our Privacy Policy.
Global City Media, and its associated brands will use the lawful basis of legitimate interests to use
the
contact details you have supplied to contact you regarding our publications, events, training,
reader
research, and other relevant information. We will always give you the option to opt out of our
marketing.
By clicking submit, you confirm that you understand and accept the Terms & Conditions and Privacy Policy
McDermott Will & Emery, the health care law firm, has acquired Farragut Square Group, a health care research and advisory firm. Farragut’s regulatory and reimbursement experts will join McDermott+Consulting, the firm’s policy, lobbying and data analytics health care consultancy.
Complementary businesses
This combination brings together two highly complementary businesses to create a comprehensive data-driven health care and life sciences consultancy and provide real synergies for clients. McDermottPlus will bring a full suite of policy advisory services backed by deep domain expertise ranging from medtech and life sciences to health care services on one platform. “The health care universe is constantly changing and we’re committed to helping our clients move faster and stay ahead of the curve,” said McDermott Will & Emery chairman Ira Coleman. “Extending our range of services in this important industry allows us to support our clients in new and innovative ways that best suit their needs. We are proud to be the top health law firm, but our greatest satisfaction comes from delivering unmatched excellence to our clients, making their lives easier and their organizations even more successful.”
Advisory platform
Farragut Square Group’s co-founder and ceo, Alina DiDonato said “Today’s news demonstrates our deep commitment to providing best-in-class regulatory, reimbursement and payment advice to private equity sponsors, their portfolio companies, banks, lenders and corporations. By intentionally choosing to partner with the most respected data-driven authority in health services and products in the Washington policy world, we’ve created a first-of-its-kind, unmatched health care advisory platform. Together, we can provide continuity throughout the pre-to-post-acquisition transaction process, both buy and sell side, with data-backed analytics that enhance our already market-leading diligence reports, medical audit capabilities and payer strategy work.” Whether clients are looking for a ‘one-stop’ provider or they want to utilize specific services, McDermottPlus offers a nimble and focused platform designed to meet their needs in the ever-changing health care universe.
Email your news and story ideas to: [email protected]